Glanz: Aging daily 107db3e59a6a490e83143e737188e3b1 5e45eb718b24

2026-10-10T06:08:34Z

Aging daily 107db3e59a6a490e83143e737188e3b1 5e45eb718b24

Neue Seite

__NOTOC__
<div class="aging-research-world aging-journal" lang="en">
<div class="aj-masthead"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aging-languages" role="navigation" aria-label="Sprache / Language"><span class="aging-language" title="Deutsch">[[Altern/Forschungsberichte/2026-10-10|🇩🇪]]</span><span class="aging-language" title="English">[[Aging/Research reports/2026-10-10|🇬🇧]]</span></div></div>
<div class="aj-context"><strong>An evolving AI research project</strong>[[Aging/About the project|Background · goals · methods]]<span>Updated 10 Oct 2026</span></div>
<h1>TIMP2: Three studies—how independent is the evidence?</h1>
<div class="aj-deck">Research report · 10 October 2026 · Source dependencies and replication</div>
<div class="aj-article">

<div class="aj-pullquote">How much does another study add when teams, protocols or technical advice are connected?</div>
'''Project status: 🔵 Level 2 · AG-C03 / AG-T01.''' Our synthesis still requires testing. '''Scientific evidence: preclinical literature; today’s task audits source dependencies.''' No new efficacy finding or independent experimental confirmation by this project.

== The central finding ==
The TIMP2 literature contains different experiments. Their independence cannot be inferred from publication counts. Today we document specific connections that were previously unresolved. All three remain registry studies; this does not increase the established independent confirmation of the project mechanism.

== Three connections across the sources ==
{| class="wikitable"
! Source pair !! Documented connection
|-
| AG-R05 (2017) ↔ AG-R01 (2026) || Shared author Joseph Castellano; AG-R01 refers to the earlier treatment protocol. [https://www.nature.com/articles/nature22067 R05] [https://www.nature.com/articles/s41467-026-74906-z R01]
|-
| AG-R05 (2017) ↔ AG-R08 (2023) || AG-R08 acknowledges Tony Wyss-Coray, an AG-R05 author. No shared author name was found in the inspected complete lists. [https://www.nature.com/articles/nature22067 R05] [https://www.eneuro.org/content/10/6/ENEURO.0031-23.2023 R08]
|-
| AG-R08 (2023) ↔ AG-R01 (2026) || AG-R01 acknowledges Eva Czirr, an AG-R08 author, for advice on microglial isolation/culture. No shared author name in the inspected lists. [https://www.eneuro.org/content/10/6/ENEURO.0031-23.2023 R08] [https://www.nature.com/articles/s41467-026-74906-z R01]
|}

'''Record interests and materials separately:''' AG-R05 discloses Alkahest interests, AG-R08 Alkahest/Grifols employment, and AG-R01 a TIMP2 patent licensed to Alkahest. AG-R01 specifies recombinant mouse TIMP2 from R&D Systems; AG-R08 describes human TIMP2 constructs, including variants, produced by Proteos/Grifols. An identical protein batch is not established. [https://www.nature.com/articles/nature22067 R05: interests] [https://www.eneuro.org/content/10/6/ENEURO.0031-23.2023 R08: methods/interests] [https://www.nature.com/articles/s41467-026-74906-z R01: methods/interests]

== How the conclusion changes ==
'''Our inference:''' We assess independence on four separate levels: research team, protocol, material and data. A shared author or technical advice establishes a connection; it does not establish reuse of the same animals or measurements. Conversely, a different author list alone does not prove fully independent reproduction. Commercial connections are disclosed and considered in appraisal; they do not replace scrutiny of the results.

The concrete decision is to retain three different testing contexts while '''not counting them as three confirmed independent reproductions of AG-T01'''. Without suitable experimental units, comparators and uncertainties, no pooled effect is calculated. An arbitrary numerical “independence discount” would be equally unjustified.

== Mechanism and countermodel remain open ==
The previously reported functional comparison in AG-R05 is retained. The AG-R08 statistical limitation and unresolved degradation/export questions also remain. Direct neuronal or matrix effects can still account for part of the functional findings. Relationships between papers do not resolve these biological alternatives.

'''Established knowledge for this audit:''' the specifically documented bibliographic and methodological connections. '''Promising indications:''' earlier TIMP2 functional findings with their respective limitations. '''Experimental results:''' external mouse/cell findings, with no newly analysed measurements today. '''Hypothesis:''' selective harmful-cargo degradation with preserved synapses and improved function; AG-T01 stays at Level 2 with low mechanistic confidence. Persistent benefit after withdrawal, human efficacy and adequate safety are not established.

== Next executable step ==
AG-R01 cites GEO '''GSE297916/GSE297917''' as generated data. [https://www.nature.com/articles/s41467-026-74906-z Data availability] Next compare the public series metadata with the described groups and experimental units: which samples are independent, which measurements come from the same animals, and can treatment and genotype be assessed separately? The series themselves were not audited today. A reliable metadata comparison must precede any decision on a bounded analysis. Missing sample linkage must be recorded as non-identifiability.

== Source status and teaching update ==
* '''AG-R05:''' Castellano et al., Nature; first published 19 April 2017, DOI [https://doi.org/10.1038/nature22067 10.1038/nature22067].
* '''AG-R08:''' Britton et al., eNeuro; publisher date 15 June 2023, differing PMC heading 12 June 2023; first-online date still unresolved; DOI [https://doi.org/10.1523/ENEURO.0031-23.2023 10.1523/ENEURO.0031-23.2023].
* '''AG-R01:''' Hemmer, Philippi et al., Nature Communications; first published 12 August 2026, DOI [https://doi.org/10.1038/s41467-026-74906-z 10.1038/s41467-026-74906-z].
* '''Retrieved/audited: 10 October 2026.''' Targeted original sections and indexed original text; no complete repeat of effect appraisal or raw-data analysis. Correction/retraction search found no attributable new notice; not comprehensive. Source delta 0: still 28 distinct studies. New adjacent search leads not yet included; [[Aging/Search log|search log]].
* [[Aging/Evidence chain|Evidence chain]] · [[Aging/Approaches to aging|Approaches registry]] · [[Aging/Research colloquium|Professor research colloquium]]. AG-P17/18/19 cover dependencies, intervention ledgers and countermodels. No duplicate supplement; axolotl sample-linkage gaps remain open.

</div>
<div class="aj-section-title"><h2>Continue exploring</h2></div><div class="aj-tiles"><div class="aj-tile"><div class="aj-thumb">[[File:Bovine Pulmonary Artery Endothelial Cells Fluorescent Image.jpg|120px|frameless|link=Aging/Approaches to aging|alt=Fluorescence micrograph of bovine endothelial cells with labeled nuclei, actin and mitochondria.]]</div><div><div class="aj-tile-title">[[Aging/Approaches to aging|Approaches to aging]]</div><div class="aj-tile-desc">Evidence and functional outcomes</div></div></div><div class="aj-tile"><div class="aj-thumb aj-type-thumb">[[Aging/Evidence chain|→]]</div><div><div class="aj-tile-title">[[Aging/Evidence chain|Evidence chain]]</div><div class="aj-tile-desc">How studies generate new questions</div></div></div><div class="aj-tile"><div class="aj-thumb">[[File:DNA double helix.svg|120px|frameless|link=Aging/Research colloquium|alt=Schematic illustration of a DNA double helix.]]</div><div><div class="aj-tile-title">[[Aging/Research colloquium|Research colloquium]]</div><div class="aj-tile-desc">16 foundation assignments + 4 new deep dives</div></div></div></div>
<div class="aj-footer"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aj-context">[[Aging|Project overview]][[Aging/About the project|Goals & methods]][[Aging/Evidence chain|Evidence chain]]</div><div class="aj-meta">AI-assisted literature research and model building. No laboratory or clinical studies conducted by this project. No personal treatment plans.</div><div class="aj-credits">Image credits · Illustrations, not project data: [https://commons.wikimedia.org/wiki/File:Axolotl_Portrait.jpg Axolotl] — LoKiLeCh ([https://creativecommons.org/licenses/by-sa/3.0/ CC BY-SA 3.0]) · [https://commons.wikimedia.org/wiki/File:XBio_illustration_%E2%80%93_Neuron.png Neuron] — explorebiology (Explore Biology) ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0]) · [https://commons.wikimedia.org/wiki/File:DNA_double_helix.svg DNA] — Biochemlife ([https://creativecommons.org/licenses/by-sa/4.0/ CC BY-SA 4.0]) · [https://commons.wikimedia.org/wiki/File:Bovine_Pulmonary_Artery_Endothelial_Cells_Fluorescent_Image.jpg Bovine endothelial cells] — Erin Rod ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0])</div></div>
</div>
[[Category:Altern / Aging]]

Aging/Research reports/2026-10-10 - Versionsgeschichte

Glanz: Aging daily 107db3e59a6a490e83143e737188e3b1 5e45eb718b24